INSULIN RESISTANCE AND CARDIOVASCULAR RISK FACTORS
胰岛素抵抗和心血管风险因素
基本信息
- 批准号:6786649
- 负责人:
- 金额:$ 14.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-15 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:angiotensinsbaroreflexcardiovascular disorderclinical researchclinical trialsdietary sodiumdisease /disorder proneness /riskfatty acidsfree radical oxygenglucose tolerance testhuman subjecthypertensioninsulin sensitivity /resistancelow birth weight infant humanlow salt dietnuclear magnetic resonance spectroscopynutrition related tagobesityoxidative stressplethysmographyprotein isoformsprotein kinase Cvascular resistancevascular smooth muscleyoung adult human (21-34)
项目摘要
This K-24 application includes a mentoring plan and two research components which are linked together by the common theme of insulin resistance and cardiovascular risk factor clustering. In part 1 of the research plan, we plan to continue work under the current R01 and a subsequent competitive renewal to test the hypothesis that fatty acids and angiotensin induce a synergistic enhancement of oxidative stress in humans. The three specific aims are to determine (1) the effects of raising fatty acids and angiotensin singly and in combination on markers of platelet PKC activity and oxidative stress (2) the effects of a low NaCl diet, which raises plasma angiotensin II, on markers of oxidative stress in obese hypertensive patients during treatment, with an AT1 receptor antagonist compared to placebo 3) which protein kinase C (PKC) isoform isoform(s) are stimulated by oleic acid and lead to the generation of reactive oxygen species and activation of extracellular signal-regulated kinases in human aortic smooth muscle cells by using antisense oligonucleotides to specific PKCs. Each of these specific aims will be addressed using methods which are well established in our patient-oriented clinical and bench research. In part 2, with the support of this K-24 Award, we plan to extend the generalizability of our findings to the wider community and by addressing important gaps in the literature on low birth weight and cardiovascular risk. We will test the hypothesis that low birth weight contributes to cardiovascular risk and salt sensitivity in a biracial sample of young adults at two college campuses in South Carolina. Three specific aims will be addressed to determine the relationships of low birth weight (<2500 grams) to (1) metabolic components of insulin resistance (oral glucose tolerance test and dyslipidemia (NMR lipid profile) (2) hemodynamic components of the insulin resistance syndrome including laboratory and 24-hour ambulatory blood pressure (BP), baroreflex sensitivity (cross spectral analysis of systolic BP and heart rate), proximal and distal arterial compliance (HDI pulse-wave) and post-ischemic forearm vascular resistance (venous occlusion plethysmography). (3) Salt sensitivity defined by the differences in BP on 180 vs. 80 mmol/d NaCl diets. All of the mentoring activities, which would be supported by the K-24 Award, also relate to various facets of the insulin resistance syndrome. "Access to excess" calories and labor saving devices has produced an epidemic of obesity and cardiovascular risk factors related to insulin resistance. While lifestyle changes are important and the PI and his colleagues work diligently in this area most people are unable to normalize their risk through lifestyle changes alone. We believe that a better definition of the pathophysiological common denominators and key intracellular signaling events mediating these effects will provide the basis for novel therapeutic approaches to cardiovascular disease prevention.
这个K-24应用程序包括一个指导计划和两个研究组成部分,它们通过胰岛素抵抗和心血管风险因素聚类的共同主题联系在一起。在研究计划的第1部分中,我们计划在当前R 01和随后的竞争性更新下继续工作,以检验脂肪酸和血管紧张素诱导人体氧化应激协同增强的假设。这三个具体目的是确定(1)单独和联合增加脂肪酸和血管紧张素对血小板PKC活性和氧化应激标志物的影响(2)在治疗期间增加血浆血管紧张素II的低NaCl饮食对肥胖高血压患者氧化应激标志物的影响,3)其中蛋白激酶C(PKC)同种型同种型被油酸刺激并导致活性氧物质的产生和细胞外信号的激活,通过使用特异性PKCs的反义寡核苷酸在人主动脉平滑肌细胞中调节激酶。这些具体目标中的每一个都将使用在我们以患者为导向的临床和实验室研究中确立的方法来解决。在第2部分中,在K-24奖的支持下,我们计划将我们研究结果的普遍性扩展到更广泛的社区,并解决低出生体重和心血管风险文献中的重要空白。我们将在南卡罗来纳州的两所大学校园的年轻成年人的双胞胎样本中检验低出生体重有助于心血管风险和盐敏感性的假设。三个具体目标将被解决,以确定低出生体重的关系,(<2500克)至(1)胰岛素抵抗的代谢成分(口服葡萄糖耐量试验和血脂异常(NMR血脂谱)(2)胰岛素抵抗综合征的血流动力学成分,包括实验室和24小时动态血压(BP)、压力反射敏感性(收缩压和心率的交叉频谱分析)、近端和远端动脉顺应性(HDI脉搏波)和缺血后前臂血管阻力(静脉闭塞体积描记法)。(3)盐敏感性定义为180与80 mmol/d NaCl饮食的BP差异。所有的辅导活动,这将是由K-24奖的支持,也涉及到胰岛素抵抗综合征的各个方面。“获得多余的”热量和节省劳力的设备已经产生了肥胖症和与胰岛素抵抗相关的心血管危险因素的流行。虽然生活方式的改变很重要,PI和他的同事们在这方面努力工作,但大多数人无法仅通过改变生活方式来使他们的风险正常化。我们相信,更好地定义的病理生理学常见的致病因子和关键的细胞内信号转导事件介导这些影响将提供新的治疗方法,以预防心血管疾病的基础。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cardiovascular risk factor control and treatment patterns in primary care.
初级保健中的心血管危险因素控制和治疗模式。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Hendrix,KatharineH;Lackland,DanielT;Egan,BrentM
- 通讯作者:Egan,BrentM
Controlling blood pressure in 50% of all hypertensive patients: An achievable goal in the healthy people 2010 report?
- DOI:10.1136/jim-51-06-34
- 发表时间:2003-11-01
- 期刊:
- 影响因子:2.6
- 作者:Egan, BM;Basile, JN
- 通讯作者:Basile, JN
Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women.
非洲裔美国年轻男性和女性自我报告的身高和体重与当前和理想身体形象之间的一致性。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:3.2
- 作者:Gilliard,TheodoshaS;Lackland,DanielT;Mountford,WilliamK;Egan,BrentM
- 通讯作者:Egan,BrentM
Ethnic differences in the treatment and control of hypertension in patients with diabetes.
糖尿病患者高血压治疗和控制的种族差异。
- DOI:10.1111/j.1524-6175.2005.04542.x
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Riehle,JessicaFlynn;Lackland,DanielT;Okonofua,EniC;Hendrix,KatherineH;Egan,BrentM
- 通讯作者:Egan,BrentM
An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients.
对初级保健机构医疗服务不足的患者高血压临床实践中的种族差异进行评估。
- DOI:10.1111/j.1524-6175.2004.03089.x
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Lackland,DanielT;Lin,Yan;Tilley,BarbaraC;Egan,BrentM
- 通讯作者:Egan,BrentM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRENT M EGAN其他文献
BRENT M EGAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRENT M EGAN', 18)}}的其他基金
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
控制难治性高血压的血压:一项试点研究
- 批准号:
8031912 - 财政年份:2011
- 资助金额:
$ 14.92万 - 项目类别:
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
控制难治性高血压的血压:一项试点研究
- 批准号:
8270475 - 财政年份:2011
- 资助金额:
$ 14.92万 - 项目类别:
PROTEOMIC ANALYSIS OF BLOOD: ZN-ALPHA-2-GLYCOPROTEIN AS A BIOMARKER FOR CACHE
血液蛋白质组分析:ZN-ALPHA-2-糖蛋白作为缓存生物标志物
- 批准号:
7719594 - 财政年份:2008
- 资助金额:
$ 14.92万 - 项目类别:
INSULIN RESISTANCE AND CARDIOVASCULAR RISK FACTORS
胰岛素抵抗和心血管风险因素
- 批准号:
6388643 - 财政年份:2000
- 资助金额:
$ 14.92万 - 项目类别:
INSULIN RESISTANCE AND CARDIOVASCULAR RISK FACTORS
胰岛素抵抗和心血管风险因素
- 批准号:
6526989 - 财政年份:2000
- 资助金额:
$ 14.92万 - 项目类别:
INSULIN RESISTANCE AND CARDIOVASCULAR RISK FACTORS
胰岛素抵抗和心血管风险因素
- 批准号:
6657302 - 财政年份:2000
- 资助金额:
$ 14.92万 - 项目类别:
INSULIN RESISTANCE AND CARDIOVASCULAR RISK FACTORS
胰岛素抵抗和心血管风险因素
- 批准号:
6798949 - 财政年份:2000
- 资助金额:
$ 14.92万 - 项目类别:
相似国自然基金
气体信号分子硫化氢对颈动脉窦压力反射感受器的调节作用及机制
- 批准号:81100181
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Injectrode- An injectable, easily removable electrode as a trial lead for baroreceptor activation therapy to treat hypertension and heart failure
Injectrode——一种可注射、易于拆卸的电极,作为压力感受器激活疗法的试验引线,以治疗高血压和心力衰竭
- 批准号:
10697600 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Midlife cardiovascular stress physiology and preclinical cerebrovascular disease
中年心血管应激生理学与临床前脑血管疾病
- 批准号:
10720054 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Alcohol use, physical activity, and neurophysiological indicators of behavioral adaptability
饮酒、体力活动和行为适应性的神经生理学指标
- 批准号:
10609697 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Sodium channel mutations as a possible cause for primary dysautonomia
钠通道突变可能是原发性自主神经功能障碍的原因
- 批准号:
10586393 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Effects of Resonance-Frequency Breathing on Preclinical Alzheimer’s Disease Biomarkers and Cognition
共振频率呼吸对临床前阿尔茨海默病生物标志物和认知的影响
- 批准号:
10591329 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Smoking-related Differences in Baroreflex Sensitivity and Fear Inhibition in Adults Who Do and Do Not Smoke Cigarettes
吸烟和不吸烟的成年人压力感受反射敏感性和恐惧抑制的与吸烟相关的差异
- 批准号:
10607239 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Examination of the influence of arterial baroreflex on physiological and psychological activity on evoking social pain
检查动脉压力反射对生理和心理活动对引起社会疼痛的影响
- 批准号:
23K12869 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Enhancing Sympathetic Outflow Control Following Spinal Cord Injury Using Targeted Plasticity Therapy
使用靶向可塑性疗法增强脊髓损伤后的交感神经流出控制
- 批准号:
10637220 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Neural and Renal Contributions to Hypertension with Androgen Deprivation Therapy
雄激素剥夺疗法对高血压的神经和肾脏影响
- 批准号:
10662133 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:
Vasomotor symptoms of menopause and cardiovascular disease: What is the link?
更年期的血管舒缩症状和心血管疾病:有什么联系?
- 批准号:
10739661 - 财政年份:2023
- 资助金额:
$ 14.92万 - 项目类别:














{{item.name}}会员




